Amgen Inc.
Organization details
- Legal name
- Amgen Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Thousand Oaks
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AMGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000318154
- EIN
- 95-3540776
- Wikidata ID
- Q470517
Board of directors
-
Amy E. Miles · DirectorSince 2023
-
Brian Druker · DirectorSince 2023
-
Charles M. Holley · DirectorSince 2023
-
David W. Gibbs · DirectorSince 2026
-
Ellen Jamison Kullman · DirectorSince 2023
-
Greg C. Garland · DirectorSince 2023
-
Mary E. Klotman · DirectorSince 2024
-
Michael Drake V · DirectorSince 2023
-
Omar Ishrak · DirectorSince 2023
-
R. Sanders Williams · DirectorSince 2023
-
Robert A. Bradway · Director · Chairman, CEO and PresidentSince 2023
-
Robert Eckert · DirectorSince 2023
-
Ronald D. Sugar · DirectorSince 2023
-
Tyler Jacks · DirectorSince 2023
-
Wanda M. Austin · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.8%
-
95.0%
-
95.3%
-
97.1%
-
97.7%
-
98.4%
-
98.7%
-
98.8%
-
98.9%
-
99.0%
-
99.3%
Board connections
12 of this board's directors also sit on 20 other boards. 2 are in the same sector.
- via Ronald D. Sugar and Wanda M. Austin
- via Amy E. Miles and Charles M. Holley
- via Charles M. Holley and Greg C. Garland
- via Robert Eckert and Ronald D. Sugar
- via Wanda M. Austin
- via Ellen Jamison Kullman
- via Omar Ishrak
-
Labcorp Holdings Inc. Same sectorvia R. Sanders Williams
- via Robert Eckert
- via Robert Eckert
- via Amy E. Miles
- via David W. Gibbs
-
Tenaya Therapeutics Inc. Same sectorvia R. Sanders Williams
- via Robert A. Bradway
- via Amy E. Miles
- via Ellen Jamison Kullman
- via Tyler Jacks
- via David W. Gibbs
- via Wanda M. Austin
- via David W. Gibbs
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $29,330,760
- 14 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Michael Drake V Director | Grant or award | +114 | — | — |
| Nov 6, 2026 | David W. Gibbs Director | Grant or award | +278 | — | — |
| Nov 6, 2026 | Charles M. Holley Director | Grant or award | +185 | — | — |
| Nov 6, 2026 | Omar Ishrak Director | Grant or award | +152 | — | — |
| Aug 13, 2026 | Khosla Rachna Officer (SVP, Business Development) | Option exercise | +1,252 | $162.60 | $203,575 |
| Aug 13, 2026 | Khosla Rachna Officer (SVP, Business Development) | Open-market sale | −1,252 | $416.43 | $521,370 |
| Aug 11, 2026 | Khosla Rachna Officer (SVP, Business Development) | Open-market sale | −2,000 | $412.57 | $825,140 |
| Aug 7, 2026 | Michael Drake V Director | Grant or award | +64 | — | — |
| Aug 7, 2026 | Charles M. Holley Director | Grant or award | +103 | — | — |
| Aug 7, 2026 | Omar Ishrak Director | Grant or award | +85 | — | — |
| Aug 7, 2026 | Busch Matthew C. Officer (VP, Finance & CAO) | Grant or award | +730 | — | — |
| Aug 6, 2026 | Grygiel Nancy A. Officer (SVP & CCO) | Option exercise | +1,970 | $177.46 | $349,596 |
| Aug 6, 2026 | Miller Derek Officer (SVP, Human Resources) | Option exercise | +2,069 | $162.60 | $336,419 |
| Aug 6, 2026 | Grygiel Nancy A. Officer (SVP & CCO) | Open-market sale | −1,970 | $402.16 | $792,255 |
| Aug 6, 2026 | Miller Derek Officer (SVP, Human Resources) | Open-market sale | −2,069 | $402.54 | $832,855 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Amgen Inc.
Who is the CEO of Amgen Inc.?
Robert A. Bradway is Amgen Inc.'s Chairman, CEO and President.
How many directors are on Amgen Inc.'s board?
Amgen Inc.'s board has 15 directors: Amy E. Miles, Brian Druker, Charles M. Holley, David W. Gibbs, Ellen Jamison Kullman, Greg C. Garland, Mary E. Klotman, Michael Drake V, Omar Ishrak, R. Sanders Williams and 5 others.
Are Amgen Inc. insiders buying or selling shares?
Over the last 12 months, Amgen Inc. insiders made no open-market purchases and sold $29.3 million of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="amgen-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.